KANG up +7.72% percent right now. $KANG High is at 18.73

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 1:58 PM

KANG up +7.72% percent right now. $KANG High is at 18.73 and the Low 17.40 with current volume of 135,943.

Recent News posted below.

KANG Ikang Healthcare Group Inc. Recent Headline News

iKang Healthcare Group, Inc. Schedules 2014 Unaudited Second Quarter Earnings Release on November 24, 2014
GlobeNewswire - Mon Nov 10, 7:45AM CST
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue, today announced that it will release its unaudited financial results for the second quarter ended September 30, 2014 on November 24, 2014 after the US market closes.
KANG: 18.71 (+1.35)

5 Stocks Poised for Breakouts
at The Street - Fri Oct 03, 1:22PM CDT
These stocks look ready to break out and trade higher from current levels.
WFM: 47.84 (+1.03), FLL: 1.30 (+0.01), CNAT: 7.00 (+0.15), KANG: 18.71 (+1.35), FUEL: 16.93 (+0.37), ZU: 28.60 (+0.10)

Tarena Is Rare Among Recent IPOs: It's Making Money
at Investor's Business Daily - Wed Sep 03, 4:06PM CDT
The April initial public offering Tarena International is among a small group of recent IPOs with a profitable history. Many IPOs debut with just a promise of profits. Some only recently turned profitable. Others, however, have shown progressively...
GPRO: 76.08 (-2.98), KANG: 18.71 (+1.35), TEDU: 14.14 (+0.26)

iKang Healthcare Slumps: KANG Plunges 13.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:41AM CDT
iKang Healthcare has been witnessing a flat earnings estimate record and its share price has been falling for past one day
AIRM: 43.38 (+0.43), KANG: 18.71 (+1.35), CRL: 63.80 (+0.44), ICLR: 53.29 (+0.68)

iKang Healthcare Group, Inc. (KANG) Jumps: Stock Surges 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:11AM CDT
iKang Healthcare Group, Inc. (KANG) was a big mover last session, as the company saw its shares rise over 10% on the day.
AIRM: 43.38 (+0.43), KANG: 18.71 (+1.35), CRL: 63.80 (+0.44), ICLR: 53.29 (+0.68)

Consensus Estimates Correction by Thomson Reuters & Reaffirmation of Guidance for Fiscal Year Ending March 31, 2015
GlobeNewswire - Tue Aug 26, 6:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, today issued a statement to clarify that the consensus estimate of iKang's net revenue for the fiscal year ending March 31, 2015 reported by Thomson Reuters was incorrectly stated to be US$323 million while the correct number should be US$289.1 million. Thomson Reuters corrected the consensus estimate number to US$289.1 million at 1:00pm Hong Kong time on August 26, 2014.
KANG: 18.71 (+1.35)

IKANG
at Investor's Business Daily - Mon Aug 25, 6:00PM CDT
IKANG (KANG), a Chinese health care service provider, said that Q1 earnings per ADR (American Depositary Receipt) rose 44% to 13 cents ex items, missing by 4 cents. Revenue rose 43% to $60 mil, missing. IKang reaffirmed its '15 revenue growth...
KANG: 18.71 (+1.35)

iKang Announces Unaudited Financial Results for Fiscal First Quarter Ended June 30, 2014
GlobeNewswire - Mon Aug 25, 4:00PM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, today announced its unaudited financial results for the fiscal first quarter ended June 30, 2014.
KANG: 18.71 (+1.35)

Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs
at Investor's Business Daily - Mon Aug 25, 1:54PM CDT
Major averages held on to decent gains with a little over one hour remaining in Monday's session. After topping the 2000 level, the S&P 500 rallied 0.5%; the Dow Jones industrial average also gained 0.5% while the Nasdaq tacked on 0.3%. Nasdaq volume...
QIHU: 74.13 (+2.84), BIIB: 325.08 (+4.33), GILD: 107.21 (+0.76), ITMN: 73.89 (-0.02), KANG: 18.71 (+1.35), ALXN: 193.97 (+0.16), ATHM: 44.43 (+0.80), CELG: 107.65 (+1.20)

Your Weekly Review: Winning Stocks Have Solid Sponsorship
at Investor's Business Daily - Thu Aug 21, 4:48PM CDT
Every Friday, Your Weekly Review presents a list of leading stocks throughout IBD's 197 industry groups. Many are showing relative price strength supported by strong fundamentals. In the table below, sponsorship data are shown in the last four...
AIRM: 43.38 (+0.43), IHS: 128.69 (-0.21), KANG: 18.71 (+1.35), BCEI: 41.78 (-1.59)

iKang To Attend Deutsche Bank Annual Global Emerging Markets Conference in New York
GlobeNewswire - Thu Aug 21, 7:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, announced today it will attend the Deutsche Bank 13 Annual Global Emerging Markets 1-on-1 Conference to be held on September 3 to 4 in New York.
KANG: 18.71 (+1.35), DB: 29.97 (-0.27)

iKang to Attend J.P. Morgan Asia Pacific Equity Conference in Boston
GlobeNewswire - Wed Aug 20, 7:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, announced today it will attend the J.P. Morgan Asia Pacific Equity Conference to be held on September 3 to 4 at Ritz-Carlton Hotel in Boston.
JPM: 61.76 (+0.29), KANG: 18.71 (+1.35)

Nasdaq Leads Up Session; Strong Earnings Lift Tata Motors
at Investor's Business Daily - Mon Aug 11, 3:20PM CDT
An up day for the market Monday saw the Nasdaq outperform as geopolitical concerns took a back seat -- at least for a day. At the close, the Nasdaq ended off its high but still rose 0.7%; the S&P 500 added 0.3% and the Dow Jones industrial average...
LEJU: 14.39 (+0.41), MYGN: 32.51 (-2.38), KANG: 18.71 (+1.35), PCLN: 1,110.69 (+16.08), BITA: 81.66 (+2.35), ATHM: 44.43 (+0.80), TTM: 46.45 (-0.09), FFIV: 126.70 (+0.04), PE: 16.46 (+0.04), KATE: 29.93 (-0.44), KING: 13.75 (+0.03)

iKang Healthcare Group, Inc. Schedules 2014 Unaudited First Quarter Earnings Release on August 25, 2014
GlobeNewswire - Thu Aug 07, 7:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, today announced that its Board of Directors has named Ms. Qing Liu as an independent director of the Company, effective July 31, 2014.
KANG: 18.71 (+1.35)

Covance Earnings Beat, Revenues Meet Estimates, View Tweaked - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 2:10PM CDT
Covance (CVD) reported adjusted earnings per share (EPS) of 95 cents in the second quarter of 2014, beating the Zacks Consensus Estimate by 2 cents or 2.2%.
OCR: 68.72 (+0.75), PRXL: 54.16 (+0.19), KANG: 18.71 (+1.35), CVD: 100.77 (+0.25)

Healthways Beats on Q2 Earnings and Revenues, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 2:00PM CDT
Healthways Inc. (HWAY) affirmed its 2014 financial guidance and expects adjusted earnings in the range of 11 to 26 cents per share for the year.
OCR: 68.72 (+0.75), PRXL: 54.16 (+0.19), KANG: 18.71 (+1.35), HWAY: 15.07 (-0.07)

Omnicare Q2 Earnings Beat, Revs up on Strong Segment Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 10:30AM CDT
Omnicare Inc. (OCR) reaffirmed its previously announced adjusted earnings and revenue guidance and updated its operating cash flow guidance for 2014.
OCR: 68.72 (+0.75), PRXL: 54.16 (+0.19), Q: 57.23 (+0.02), KANG: 18.71 (+1.35)

iKang to Attend Bank of America Merrill Lynch Healthcare Corporate Day in Hong Kong
GlobeNewswire - Thu Jul 10, 7:00AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, announced today it will attend the Bank of America Merrill Lynch Healthcare Corporate Day to be held on July 16 to 17 at Bank of America Merrill Lynch Client Centre, 55/F Cheung Kong Centre, 2 Queen's Road, Hong Kong.
KANG: 18.71 (+1.35)

iKang Announces Appointment of New Independent Director
GlobeNewswire - Tue Jul 08, 8:24AM CDT
iKang Healthcare Group, Inc. ("iKang" or the "Company"

(Nasdaq:KANG), the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, today announced that the Board of Directors of the Company (the "Board"

has appointed and designated Ms. Ruby Lu as an independent director of the Company and a member of the audit committee of the Board, effective July 5, 2014. Ms. Bonnie Sum Wai Lo has resigned from the Company's Board, effective July 5, 2014.
KANG: 18.71 (+1.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...